Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, Phenomics Australia and TIA support a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure (NRI) Roadmap. Collectively, they offer academic researchers and SMEs access to a diverse range of Australian translational medical research capabilities, from the molecular basis of health and disease through to clinical trials.

To encourage access to these capabilities, Phenomics Australia is partnering with TIA to offer a voucher-style scheme that can subsidised the cost of access to a full range of advanced capabilities to expand the list of translation expertise necessary for the discovery and translation of medical research.

This scheme aims to support therapeutic development projects by providing up to $50,000 with at least 50% matching funding (co-investment) by the applicant.

Contact a Phenomics Australia or TIA facility and they will assist you in your application (Contact details for each facility can be found in the guideline document).

For more information:

If you have any questions regarding their voucher schemes, a virtual information session will be held on the 14th of March 2023, 12pm AEST Register here.

Alternatively, contact us at


Applications close on 28th April 2023, 5pm (AEST).